These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4946080)

  • 1. Preliminary report from the Scandinavian adjuvant chemotherapy study group.
    Nissen-Meyer R; Kjellgren K; Mansson B
    Cancer Chemother Rep; 1971 Dec; 55(5):561-6. PubMed ID: 4946080
    [No Abstract]   [Full Text] [Related]  

  • 2. Extended surgical adjuvant thiotepa for mammary carcinoma.
    Donegan WL
    Arch Surg; 1974 Aug; 109(2):187-92. PubMed ID: 4211024
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Cooperative clinical trials in primary breast cancer: a critical appraisal.
    Fisher B
    Proc Natl Cancer Conf; 1972; 7():285-302. PubMed ID: 4587648
    [No Abstract]   [Full Text] [Related]  

  • 4. Cooperative clinical trials in primary breast cancer: a critical appraisal.
    Fisher B
    Cancer; 1973 May; 31(5):1271-86. PubMed ID: 4574458
    [No Abstract]   [Full Text] [Related]  

  • 5. [Radiation and concomitant chemotherapy after surgery for breast cancer].
    Calais G
    Cancer Radiother; 2004 Feb; 8(1):39-47. PubMed ID: 15093200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical trials in breast cancer: a tabular summary. Part 1: Primary breast cancer.
    Conrad B; Kieser R
    Arch Geschwulstforsch; 1986; 56(3):211-36. PubMed ID: 3524501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous postoperative treatment with cyclophosphamide in breast carcinoma--a randomized clinical study.
    Rieche K; Berndt H; Prahl B
    Arch Geschwulstforsch; 1972; 40(4):349-54. PubMed ID: 4650821
    [No Abstract]   [Full Text] [Related]  

  • 8. [Does primary chemotherapy really increase the rate of breast conserving treatments?].
    Hennequin C; Espié M; Misset JL; Maylin C
    Cancer Radiother; 2004 Feb; 8(1):48-53. PubMed ID: 15093201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer: pros and cons of conservative vs aggressive management.
    Davidson AT
    J Natl Med Assoc; 1981 Nov; 73(11):1089-92. PubMed ID: 7031277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Scandinavian clinical trials.
    Nissen-Meyer R
    Experientia Suppl; 1982; 41():571-9. PubMed ID: 6958539
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant long-term chemotherapy in complex treatment of operable breast cancer.
    Kholdin SA; Deemarsky LY; Bavly JL
    Cancer; 1974 Apr; 33(4):903-6. PubMed ID: 4206571
    [No Abstract]   [Full Text] [Related]  

  • 12. Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation.
    Fisher B; Ravdin RG; Ausman RK; Slack NH; Moore GE; Noer RJ
    Ann Surg; 1968 Sep; 168(3):337-56. PubMed ID: 4970947
    [No Abstract]   [Full Text] [Related]  

  • 13. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
    Overgaard M; Hansen PS; Overgaard J; Rose C; Andersson M; Bach F; Kjaer M; Gadeberg CC; Mouridsen HT; Jensen MB; Zedeler K
    N Engl J Med; 1997 Oct; 337(14):949-55. PubMed ID: 9395428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wide-field radiation as adjunct to adjuvant chemotherapy in high-risk cases with early breast cancer: do it or not?
    Ragaz J; Spinelli JJ
    Int J Cancer; 2000 Aug; 87(3):423-6. PubMed ID: 10897049
    [No Abstract]   [Full Text] [Related]  

  • 16. Extended surgical adjuvant chemotherapy for breast carcinoma.
    Long RT; Donegan WL; Evans AM
    Am J Surg; 1969 May; 117(5):701-4. PubMed ID: 4978185
    [No Abstract]   [Full Text] [Related]  

  • 17. Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients.
    Levy A; Borget I; Bahri M; Arnedos M; Rivin E; Vielh P; Balleyguier C; Rimareix F; Bourgier C
    Breast J; 2014; 20(4):381-7. PubMed ID: 24890310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer.
    Ahmann DL; Bisel HF; Eagan RT; Edmonson JH; Hahn RG
    Cancer Chemother Rep; 1974; 58(6):877-82. PubMed ID: 4614896
    [No Abstract]   [Full Text] [Related]  

  • 19. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
    J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.